New studies investigate how the use of antibiotics affects the balance of both harmful and beneficial bacteria in patients undergoing stem cell transplantation.

Memorial Sloan-Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.

At Memorial Sloan-Kettering, an experienced team of physicians, nurses, and support staff care for children with the rare eye cancer retinoblastoma and their families.

A team of investigators from Memorial Sloan-Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.

Pediatric Day Hospital Medical Director Farid Boulad explains that “we’re trying to excel at caring for the entire child, physically and emotionally.”

In the largest study of genes and smoking performed in a minority population to date, researchers have discovered a gene variant that increases a person’s risk of smoking.

Memorial Sloan-Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery.